" class="no-js "lang="en-US"> Kristof Vercruysse - Medtech Alert
Friday, April 19, 2024
Kristof Vercruysse

Kristof Vercruysse

About Kristof Vercruysse

Bringing numerous drugs from Lead identification/Proof of Concept in animals to Proof of Concept in Humans.
– Strategic and Executive management.
– Integrated Project Leadership and Development
– Alignment of Pharmacology, Manufacturing and Clinical Development
– Third Party Vendor Management
– Strong Medical input and KOL network in various therapeutic areas
– Orphan Drug Experience

Related Story

TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients

February 22 2022

TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, […]